An athlete considering a peptide encounters at least two distinct questions: what the clinical evidence shows and what the applicable sport rules permit. A product can lack proven benefit and still be prohibited. A prescription or reassuring advertisement does not automatically resolve anti-doping status.

Use the rules in effect for the relevant event

The WADA 2026 Prohibited List includes categories for non-approved substances and for peptide hormones, growth factors, related substances and mimetics. The rules are broader than a short list of familiar product names. A name not appearing in a quick search should not be interpreted as permission. WADA 2026 Prohibited List

Sport-specific application and any therapeutic-use process need advice from the responsible anti-doping organization. Future-year lists may already be published before they take effect, so the date matters. This article refers to the 2026 list and is not a clearance decision for an individual athlete.

Do not confuse eligibility with efficacy

A laboratory mechanism or hormone response does not establish faster recovery or better performance. FTC guidance requires evidence appropriate to a health or performance-related claim. A testimonial from an athlete cannot replace that evidence. FTC Health Products Compliance Guidance

Product quality is another independent issue. A certificate cannot settle whether the actual contents are permitted under all applicable sport rules, and it cannot create clinical safety. For service members, separate military substance requirements may also apply, with OPSS serving as an official information resource. Department of Defense Operation Supplement Safety

AXON should keep these decisions separate rather than suggesting that a sports-oriented seller has solved them all. No product, supplier or compound is cleared for competition by this article. Athletes should seek a current, substance-specific determination through their official sport and medical channels before taking action.